Notably, serous endometrial carcinoma, which has the poorest prognosis, exhibited the highest IL4I1 expression, whereas endometrioid adenocarcinoma, associated with a better prognosis, showed only slightly elevated IL4I1 expression compared to normal endometrial tissues (Figure 2C). The gene discussed is IL4I1; the disease is endometrioid adenocarcinoma.